Dr. Sonya Abdel-Razeq has been appointed Medical Director of the Yale-New Haven Hospital Maternal Special Care Unit.
Dr. Antonette T. Dulay was awarded the Research Excellence Award - Society for Maternal Fetal Medicine at the annual meeting, Dallas, February 6-11, 2012.
Dr. Erika Werner was awarded “The March of Dimes Best Research in Prematurity” at the Society for Maternal Fetal Medicine Meeting, Dallas, February 6-11, 2012.
New Co-Directors named for Yale Maternal-Fetal Medicine Practice
Drs. Urania Magriples & Antonette Dulay have been named Co-Directors of the Yale Maternal-Fetal Medicine Practice.
- High-Risk Maternity Services
Investigators at Yale Maternal-Fetal Medicine Section discovered that Heparin (a potent anti-coagulation drug) elevates Circulating Soluble fms-Like Tyrosine Kinase-1 (sFlt-1) immunoreactivity in pregnant women.
A group of investigators at Yale Maternal-Fetal Medicine Section recently reported that in-vitro Heparin induces potentially detrimental proinflammatory and antiangiogenic profile in the trophoblast.